4D medical (ASX:4DX) announced a three-year agreement with UC San Diego (UCSD) Health, ranked among the top 10 respiratory hospitals in the United States. The agreement will bring 4DMedical’s innovative lung imaging technology into clinical use at some of the nation’s leading medical centers.

4DMedical’s XV technology transforms the way respiratory function is assessed. Traditional imaging techniques, such as X-rays and CT scans, can provide a static view of the structure of the lungs, but cannot capture how the lungs function dynamically. XV technology changes this by using motion analysis to track airflow in real time, allowing doctors to detect areas of poor lung performance earlier and more accurately.

This technology operates on a Software as a Service (SaaS) model.

With this agreement, UCSD Health will initially adopt 4DMedical’s CT-based imaging tools with the potential to expand across its portfolio, including the XV scanner. The XV scanner is a specialized lung imaging device that captures a four-dimensional view of lung function during normal breathing. Unlike standard imaging methods, it is non-invasive, does not require contrast agents, and uses less radiation than a chest x-ray. This scanner is specifically designed to work with 4DMedical’s XV Lung Ventilation Analysis Software (XV LVAS).

“This partnership with UCSD Health highlights the growing recognition of 4DMedical’s innovative technology that is transforming respiratory care,” said Managing Director and CEO Andreas Fouras. “Our status as one of the nation’s top respiratory hospitals will undoubtedly facilitate commercialization efforts within the broader U.S. health care system.”